Key Issues
Mission Statement: to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States
Funding
Ensure there is necessary federal funding for domestic HIV programs including Ryan White HIV/AIDS Program, CDC HIV Prevention (including School and Adolescent Health), NIH AIDS Research, Housing Opportunities for People with AIDS (HOPWA), Minority AIDS Initiative, sexual education and other programs included in the Ending the HIV Epidemic initiative such as Community Health Centers and the Indian Health Service.
Programs and Policies
Ensure that federal HIV programs and policies support the needs of people living with and at risk of HIV and are administered and delivered free of discrimination and stigma, fully engage relevant communities, and meet the needs of state and local communities, and allow them to best meet the goals of ending the HIV initiative, including increased HIV prevention, HIV screening, and linkage to care and treatment in order to achieve sustainable viral suppression. Ensure that funding is distributed equitably and used efficiently in order to maximally impact positive health outcomes.
Viral Hepatitis
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Funding
Ensure there is necessary federal funding for domestic viral hepatitis programs including CDC Hepatitis Prevention and others necessary to end hepatitis B and C in the United States, including those related to infectious diseases associated with the opioid epidemic.
Programs and Policies
Ensure that federal viral hepatitis programs and policies support the needs of people living with and at risk of hepatitis and are administered and delivered free of discrimination and stigma, fully engage relevant communities and meet the needs of state and local communities, and allow them to best meet the goals of ending hepatitis by increased hepatitis prevention, hepatitis screening, and linkage to care and treatment, including curative treatments. Ensure that funding is distributed equitably and used efficiently in order to maximally impact positive health outcomes.
Healthcare Access
Promote programs and policies that provide healthcare to people with HIV, hepatitis, and other serious and chronic conditions
Programs
Ensure that people with and at risk of HIV, hepatitis, and other serious and chronic health conditions have access to comprehensive, quality, and affordable healthcare that includes preventive services, including private insurance, Medicaid, Medicare, and other forms of health coverage.
Policies
Ensure that healthcare programs are patient-focused so that people can receive the quality care and treatment prescribed by their provider at a cost they can afford.
Get Involved
Facebook posts by @HIV+Hep
Delta Failing Their Employees by Restricting Access to PrEP Drugs--Clear Violation of ACA Preventive Services Requirement: bit.ly/497ootO
Cuts to #HIV Prevention and Treatment Funding:
SNAP Benefits Frozen, Cuts to HIV Prevention and Treatment Funding, Bartow’s Hero of World WarII
www.cfpublic.org
As the federal government shutdown proceeds through day 37, SNAP recipients are feeling the shortfall. Federal cuts to HIV funding are having dangerous effects on efforts to educate, prevent and treat...
The HIV and Hepatitis Policy Institute's Carl Schmid testified in support of Zachary Parker, Ward 5 Member, DC State Board of Education's #PrEP DC Act of 2025 that prohibits #copays & #priorauthorizations for all PrEP & PEP #Rx so that DC residents can access the latest #HIV prevention drugs w/o relying on federal mandates:
Support for PrEP DC Act of 2025 (B26-0159) | HIV+Hepatitis Policy Institute
bit.ly
Testimony by Carl Schmid Executive Director, HIV+Hepatitis Policy Institute in support of PrEP DC Act of 2025 (B26-0159) Committee on Health, Council of the District of Columbia October 30, 2025
CVS Caremark tells #Aids activists Gilead needs to lower the price of its new #HIV drug to get on formularies:
www.statnews.com
CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on formularies, according to an email obtained by STAT.
Appeals Court Takes Up Whether Iowa’s PBM Law Rightfully Bans Copay Accumulators: insidehealthpolicy.com/daily-news/appeals-court-takes-whether-iowa-s-pbm-law-rightfully-bans-copa...